PharmaTher Signs Exclusive Worldwide License Agreement for
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery forms and formulations of ketamine for mental health,...
Source: globenewswire.com
Stay updated with breaking news from Ketamine Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery forms and formulations of ketamine for mental health,...
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery forms and formulations of ketamine for mental health,...